GenScript ReadyEdit LNP: Streamlined Delivery for Gene Editing Research
GenScript ReadyEdit LNP solutions are designed to support efficient delivery of gene editing payloads for research applications, including CRISPR-based genome editing and in vivo gene editing studies. By combining optimized lipid nanoparticle (LNP) formulations with pre-validated editing components, GenScript helps simplify and accelerate gene editing workflow development.
Receive your quote directly from the manufacturer.
GenScript offers ReadyEdit LNP solutions to streamline gene editing research by providing optimized lipid nanoparticle (LNP) systems for efficient delivery of gene editing payloads. Built on GenScript’s expertise in mRNA synthesis, gene editing technologies, and LNP formulation, the ReadyEdit platform is designed to support reliable and convenient genome editing workflows for both in vitro and in vivo research applications.
The ReadyEdit LNP platform supports the delivery of CRISPR-based gene editing components, including Cas9 mRNA and sgRNA payloads, using optimized LNP formulations developed for high transfection efficiency and robust editing performance. These solutions are suitable for applications such as functional genomics research, cell engineering, therapeutic discovery, and early-stage in vivo gene editing studies.
With integrated capabilities in payload preparation, LNP formulation, characterization, and analytical testing, GenScript provides end-to-end support to help researchers reduce development time, simplify experimental setup, and accelerate gene editing research programs.
Advance therapeutic development with mRNA manufacturing solutions
By utilizing in vitro transcribed (IVT) messenger RNA (mRNA) molecules, scientists can deliver specific instructions to cells, directing them to produce therapeutic proteins or trigger desired immune responses.
GenScript utilizes advanced gene synthesis platforms along with plasmid preparation and linearization services to produce best in class IVT templates. Building on that expertise, GenScript has created an integrated manufacturing workflow that spans from codon-optimized genes to mRNA Production to Lipid Nanoparticle (LNP) delivery.
Dowload this eBook to find out how to:
- Achieve superior quality in IVT mRNA
- Drive new therapy modalities
- Enhance protein expression with circular RNA
- Deliver your therapeutics efficiently and safely
- Optimize the performance of your therapeutics
